- NIHR chief scientific adviser visits Huddersfield health innovation campus
- One in three UK women with migraine say symptoms taken less seriously
- Report highlights scope to expand day surgery
- Sygnature formalises drug discovery collaboration with X-Chem
- Codis appoints Steven Facer as chief commercial officer
- Danish medical cannabis use rises as regulator reports no new safety signals
- Equity starts with listening: putting community voices at the centre of access
- Global coalition calls for stronger government action on COPD
- Global health researchers call for more equitable partnerships
- Liverpool launches £20m lab for infectious disease drug discovery
- Circle Health Group expands into UK laboratory operations
- FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
- Pharma sees climate disruption as growing supply-chain risk
- Manchester NHS-MHRA partnership to test new technologies in real-world care
- Ondine reports 40% reduction in surgical-site infections in phase 3 trial